Haifeng Huang leads the Firm's Greater China intellectual property practice and has more than 20 years of experience in cross-border disputes and transactional matters. He is regularly called upon to lead teams and advise clients on their complex business disputes with high-technology components and intellectual property matters involving patents, trademarks, copyrights, trade secrets, unfair competition, antitrust, and technology licenses.
Haifeng has successfully guided representations in high-stakes litigation for many of the world's leading companies in a diverse range of industries, including software and systems, semiconductors, microelectronics, telecommunications, robotics, pharmaceuticals, medical devices, biotechnology, textiles, chemicals, optics, consumer products, and heavy machinery.
He also manages due diligence and transactions and negotiates agreements involving the acquisition, license, and commercialization of intellectual property assets, including research and development (R&D) collaborations, sponsored research, joint development, clinical trials, cross-licensing, strategic alliance, manufacturing, distribution, consulting, and software services.
Haifeng was endorsed by clients and peers in Chambers Global as being "strategic, very reliable and trustworthy" and having a "top-notch IP practice" in China. The WTR 1000 also described him as "one of the country's most seasoned litigators, with a history of representing large U.S. and Chinese concerns in high-stakes disputes."
Haifeng is a Fellow of the Chartered Institute of Arbitrators (FCIArb). He is a member of Harvard Law School's Leadership Council and has also served as a council member for the China Intellectual Property Law Society. He has been an instructor at Renmin University of China Law School's Juris Master Program and has taught advanced courses at the University of Hong Kong.
经验
其他出版物
- 2022
Uncovering Trade Secrets in China: An Empirical Study of Civil Litigation from 2010 to 2020; Journal of Intellectual Property Law & Practice, Volume 17, Issue 9, 2022, Oxford University Press
- October 19, 2021
Trade Secret Enforcement in Greater China: Past Data and Recent Developments - October 7, 2021
Protection of Trademarks and Intellectual Property in China - July 21, 2021
How to Protect Your Innovative Drugs Under China's Hatch-Waxman Act - January 18, 2016
Fee Shifting Strategies for Patent Troll Litigation and IP Review in M&A Transactions - 2016年1月18日
知识产权研讨会——专利流氓诉讼的费用转移策略与并购交易中的知识产权审查 - 2016年1月18日
知識產權研討會——專利流氓訴訟的費用轉移策略與併購交易中的知識產權審查 - October 25, 2012
China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China - 2012年10月25日
在华投资研讨会:外商对华投资新的挑战和机遇 - 2012年10月23日
生命科学法律剧 - October 23, 2012
Life Science Legal Drama - "Mr. Big in Wonderland" - May 16, 2012
Demystifying Well-known Mark Recognition in China - April 13, 2012
Strategies of Defending Trade Secret Lawsuits in China and the US - February 13, 2012
Ten Common Mistakes to Avoid while Protecting Your IP Rights in China - September 21, 2011
Managing Intellectual Property in China - Realities and Pitfalls - September 9, 2011
Arbitration Clauses in Commercial Agreements - Do you know what you're signing up to? - April 16, 2011
Walking on Eggshells: Dealing with IP and Regulatory Issues in China - April 6, 2011
IP Due Diligence - November 23, 2010
Technology Transfer in China - November 22, 2010
Protecting Your Brands in China: Challenges and Opportunities - April 25, 2008
Regulatory Roadmap for Pharmaceutical Innovations in China
"Haifeng Huang is very practical, down to earth and persistent in resolving clients' issues. He is detail oriented and has 100% success rates for the disputes he handled for us."The Legal 500 Asia Pacific
- Harvard University (LL.M. 2003); Renmin University of China (LL.D. 2006; LL.M. 2001; LL.B. 1998; Founding Editor, Law Review; Executive Editor, Chinese Intellectual Property Review)
- New York (USA) and Hong Kong
2016-2017 Global Fellow, Federal Circuit Bar Association
Consistently recommended by Chambers Global and The Legal 500 for intellectual property
IAM Patent: "carved a niche on the Chinese litigation scene, routinely appearing in must-win infringement and invalidation battles"
Managing Intellectual Property: "consistently delivered favorable results ... his guidance is practical and strategic, and takes into account the nuances of the Chinese system"
- English, Mandarin
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice